ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (66)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barberà, J.A.
Right arrow Articles by Santos, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barberà, J.A.
Right arrow Articles by Santos, S.
Eur Respir J 2003; 21:892-905
Copyright ©ERS Journals Ltd 2003


Pulmonary hypertension in chronic obstructive pulmonary disease

J.A. Barberà, V.I. Peinado and S. Santos

Dept of Pulmonary Medicine, Institute of Biomedical Research Augusti Pi i Sunyer (IDIBAPS), Hospital Clinic, University of Barcelona, Spain

CORRESPONDENCE: J.A. Barberà, Servei de Pneumologia, Hospital Clínic, Villarroel 170., 08036, Barcelona, Spain. Fax: 34 932275455. E-mail: jbarbera@clinic.ub.es.

Keywords: chronic hypoxaemia, cigarette-smoke effects, endothelium, pulmonary artery, vascular remodelling, vasodilators

Received: December 12, 2002
The authors have been supported, in part, by research grants from Fondo de Investigación Sanitaria (FIS), Sociedad Española de Neumología y Cirugía Torácica (SEPAR), and Societat Catalana de Pneumologia (SOCAP).

Abstract

Pulmonary hypertension is a common complication of chronic obstructive pulmonary disease (COPD). Its presence is associated with shorter survival and worse clinical evolution. In COPD, pulmonary hypertension tends to be of moderate severity and progresses slowly. However, transitory increases of pulmonary artery pressure may occur during exacerbations, exercise and sleep. Right ventricular function is only mildly impaired with preservation of the cardiac output.

Structural and functional changes of pulmonary circulation are apparent at the initial stages of COPD. Recent investigations have shown endothelial dysfunction and changes in the expression of endothelium-derived mediators that regulate vascular tone and cell growth in the pulmonary arteries of patients with mild disease. Some of these changes are also present in smokers with normal lung function. Accordingly, it has been postulated that the initial event in the natural history of pulmonary hypertension in COPD could be the lesion of pulmonary endothelium by cigarette-smoke products.

Long-term oxygen administration is the only treatment that slows down the progression of pulmonary hypertension in chronic obstructive pulmonary disease. Nevertheless, with this treatment pulmonary artery pressure rarely returns to normal values and the structural abnormalities of pulmonary vessels remain unaltered. Vasodilators are not recommended on the basis of their minimal clinical efficacy and because they impair pulmonary gas exchange. Recognition of the role of endothelial dysfunction in the physiopathology of pulmonary hypertension in chronic obstructive pulmonary disease opens new perspectives for the treatment of this complication.




This article has been cited by other articles:


Home page
Eur Respir JHome page
D. Stolz, H. Rasch, A. Linka, M. Di Valentino, A. Meyer, M. Brutsche, and M. Tamm
A randomised, controlled trial of bosentan in severe COPD
Eur. Respir. J., September 1, 2008; 32(3): 619 - 628.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
M. R. Wilkins, J. Wharton, F. Grimminger, and H. A. Ghofrani
Phosphodiesterase inhibitors for the treatment of pulmonary hypertension
Eur. Respir. J., July 1, 2008; 32(1): 198 - 209.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. L. Wright, M. Cosio, and A. Churg
Animal models of chronic obstructive pulmonary disease
Am J Physiol Lung Cell Mol Physiol, July 1, 2008; 295(1): L1 - L15.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. Churg, M. Cosio, and J. L. Wright
Mechanisms of cigarette smoke-induced COPD: insights from animal models
Am J Physiol Lung Cell Mol Physiol, April 1, 2008; 294(4): L612 - L631.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
C. K. Lykidis, M. J. White, and G. M. Balanos
The pulmonary vascular response to the sustained activation of the muscle metaboreflex in man
Exp Physiol, February 1, 2008; 93(2): 247 - 253.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
V. Leblais, E. Delannoy, F. Fresquet, H. Begueret, N. Bellance, S. Banquet, C. Allieres, L. Leroux, C. Desgranges, A. Gadeau, et al.
{beta}-adrenergic relaxation in pulmonary arteries: preservation of the endothelial nitric oxide-dependent {beta}2 component in pulmonary hypertension
Cardiovasc Res, January 1, 2008; 77(1): 202 - 210.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
T. Hoshino, S. Kato, N. Oka, H. Imaoka, T. Kinoshita, S. Takei, Y. Kitasato, T. Kawayama, T. Imaizumi, K. Yamada, et al.
Pulmonary Inflammation and Emphysema: Role of the Cytokines IL-18 and IL-13
Am. J. Respir. Crit. Care Med., July 1, 2007; 176(1): 49 - 62.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. Dubuis
DHEA treatment of pulmonary hypertension: New insights into a complex mechanism
Cardiovasc Res, June 1, 2007; 74(3): 337 - 338.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Oka, V. Karoor, N. Homma, T. Nagaoka, E. Sakao, S. M. Golembeski, J. Limbird, M. Imamura, S. A. Gebb, K. A. Fagan, et al.
Dehydroepiandrosterone upregulates soluble guanylate cyclase and inhibits hypoxic pulmonary hypertension
Cardiovasc Res, June 1, 2007; 74(3): 377 - 387.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
A. M. Luks and E. R. Swenson
Travel to high altitude with pre-existing lung disease
Eur. Respir. J., April 1, 2007; 29(4): 770 - 792.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. P. Nana-Sinkam, J. D. Lee, S. Sotto-Santiago, R. S. Stearman, R. L. Keith, Q. Choudhury, C. Cool, J. Parr, M. D. Moore, T. M. Bull, et al.
Prostacyclin Prevents Pulmonary Endothelial Cell Apoptosis Induced by Cigarette Smoke
Am. J. Respir. Crit. Care Med., April 1, 2007; 175(7): 676 - 685.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
V. V. McLaughlin and M. D. McGoon
Pulmonary Arterial Hypertension
Circulation, September 26, 2006; 114(13): 1417 - 1431.
[Full Text] [PDF]


Home page
Eur Respir JHome page
B. Beghe, E. Bazzan, S. Baraldo, F. Calabrese, F. Rea, M. Loy, P. Maestrelli, R. Zuin, L. M. Fabbri, and M. Saetta
Transforming growth factor-{beta} type II receptor in pulmonary arteries of patients with very severe COPD
Eur. Respir. J., September 1, 2006; 28(3): 556 - 562.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
P. Joppa, D. Petrasova, B. Stancak, and R. Tkacova
Systemic Inflammation in Patients With COPD and Pulmonary Hypertension.
Chest, August 1, 2006; 130(2): 326 - 333.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
M. Witzenrath, B. Ahrens, S. M. Kube, A. C. Hocke, S. Rosseau, E. Hamelmann, N. Suttorp, and H. Schutte
Allergic lung inflammation induces pulmonary vascular hyperresponsiveness
Eur. Respir. J., August 1, 2006; 28(2): 370 - 377.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K.-O. Larsen, I. Sjaastad, A. Svindland, K. A. Krobert, O. H. Skjonsberg, and G. Christensen
Alveolar hypoxia induces left ventricular diastolic dysfunction and reduces phosphorylation of phospholamban in mice
Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H507 - H516.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
G. P. Fadini, M. Schiavon, M. Cantini, I. Baesso, M. Facco, M. Miorin, M. Tassinato, S. V. d. Kreutzenberg, A. Avogaro, and C. Agostini
Circulating Progenitor Cells Are Reduced in Patients with Severe Lung Disease
Stem Cells, July 1, 2006; 24(7): 1806 - 1813.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
V. I. Peinado, J. Ramirez, J. Roca, R. Rodriguez-Roisin, and J. A. Barbera
Identification of Vascular Progenitor Cells in Pulmonary Arteries of Patients with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Cell Mol. Biol., March 1, 2006; 34(3): 257 - 263.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
S. Provencher, X. Jais, A. Yaici, O. Sitbon, M. Humbert, and G. Simonneau
Clinical Challenges in Pulmonary Hypertension: Roger S. Mitchell Lecture
Chest, December 1, 2005; 128(6_suppl): 622S - 628S.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
S. Provencher, X. Jais, A. Yaici, O. Sitbon, M. Humbert, and G. Simonneau
Clinical Challenges in Pulmonary Hypertension: Roger S. Mitchell Lecture
Chest, December 1, 2005; 128(6_suppl): 622S - 628S.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J.-H. Lee, D.-S. Lee, E.-K. Kim, K.-H. Choe, Y.-M. Oh, T.-S. Shim, S.-E. Kim, Y.-S. Lee, and S.-D. Lee
Simvastatin Inhibits Cigarette Smoking-induced Emphysema and Pulmonary Hypertension in Rat Lungs
Am. J. Respir. Crit. Care Med., October 15, 2005; 172(8): 987 - 993.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. R. Stenmark and I. F. McMurtry
Vascular Remodeling Versus Vasoconstriction in Chronic Hypoxic Pulmonary Hypertension: A Time for Reappraisal?
Circ. Res., July 22, 2005; 97(2): 95 - 98.
[Full Text] [PDF]


Home page
ThoraxHome page
J L Wright, R D Levy, and A Churg
Pulmonary hypertension in chronic obstructive pulmonary disease: current theories of pathogenesis and their implications for treatment
Thorax, July 1, 2005; 60(7): 605 - 609.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
T. Troosters, R. Casaburi, R. Gosselink, and M. Decramer
Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., July 1, 2005; 172(1): 19 - 38.
[Full Text] [PDF]


Home page
Eur Respir JHome page
P. J. Barnes and R. A. Stockley
COPD: current therapeutic interventions and future approaches
Eur. Respir. J., June 1, 2005; 25(6): 1084 - 1106.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
G. Thabut, G. Dauriat, J. B. Stern, D. Logeart, A. Levy, R. Marrash-Chahla, and H. Mal
Pulmonary Hemodynamics in Advanced COPD Candidates for Lung Volume Reduction Surgery or Lung Transplantation
Chest, May 1, 2005; 127(5): 1531 - 1536.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
L. G. Chicoine, E. Tzeng, R. Bryan, S. Saenz, M. L. Paffett, J. Jones, C. R. Lyons, T. C. Resta, L. D. Nelin, and B. R. Walker
Intratracheal adenoviral-mediated delivery of iNOS decreases pulmonary vasoconstrictor responses in rats
J Appl Physiol, November 1, 2004; 97(5): 1814 - 1822.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
C.C. Christensen, M.S. Ryg, A. Edvardsen, and O.H. Skjonsberg
Relationship between exercise desaturation and pulmonary haemodynamics in COPD patients
Eur. Respir. J., October 1, 2004; 24(4): 580 - 586.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
O. Pauvert, S. Bonnet, E. Rousseau, R. Marthan, and J.-P. Savineau
Sildenafil alters calcium signaling and vascular tone in pulmonary arteries from chronically hypoxic rats
Am J Physiol Lung Cell Mol Physiol, September 1, 2004; 287(3): L577 - L583.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
S.M. Kawut and H.I. Palevsky
New answers raise new questions in pulmonary arterial hypertension
Eur. Respir. J., June 1, 2004; 23(6): 799 - 801.
[Full Text] [PDF]


Home page
ChestHome page
N. A. Molfino
Genetics of COPD
Chest, May 1, 2004; 125(5): 1929 - 1940.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the European Respiratory Society.